Parkinson's Flashcards

1
Q

What are the causes of Parkinson’s disease?

A

Genetic - mutation of the gene that encodes for a-synuclein and is associated with Lewy bodies

Environmental factors - MPTP exposure is a neurotoxin that kills dopaminergic neurons

Idiopathic occurs with age - in >50 or >65 year olds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What can reduce the risks of Parkinson’s?

A

Moderate consumption of coffee, alcohol and smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does drug-induced dementia occur and what should be done to stop it?

A

First generation antipsychotics or other drugs block dopamine receptors

Sodium valproate causes parkinsonian tremor

Stop the drugs, some effects of tardive dyskinesia may not be reversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the motor symptoms of Parkinson’s?

A

Bradykinesia - slow movement, shuffling gait

Rigidity - increase in muscle tone

Cog-wheeling - rigidity with tremors

Resting tremors

Postural instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the autonomic symptoms of Parkinson’s?

A

Postural hypotension

Sialorrhoea - failure to remove or retain excess saliva

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the cognitive symptoms of Parkinson’s?

A

REM sleep disorder

Hallucinations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the types of dementia in Parkinson’s and when is their onset?

A

Dementia with Lewy bodies (early onset)

Parkinson’s dementia (Late onset)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do Lewy bodies cause dementia?

A

Deposits of a-synuclein in nerve cells in the brain

Prevents sufficient functioning of neurotransmitters

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is Parkinson’s diagnosed?

A

Brain bank criteria

Imaging- for loss of dopaminergic neurons

Consideration of other factors that could cause it e.g. drugs or comorbidities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the brain bank criteria?

A

Step 1:
Bradykinesia and rigidity, rest tremor or postural instability

Step 2:
exclusion criteria

Step 3:
Good response to L-dopa

L-dopa response >5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are benefits of using a decarboxylase inhibitor

A

Benserazide - madopar

carbidopa - sinemet

Prevent the breakdown of levodopa in the periphery

Allows dopamine to cross the BBB

Lower dose of levodopa can be used, as more of it will be available in the BBB

Reduces nausea, arrhythmias and hypertension caused by peripheral dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What counselling should be given for taking levodopa?

A

Take it 30 minutes before food

Have a low protein diet, as protein reduces the absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is it difficult to treat tremors with levodopa?

A

It is a difficult motor symptom to treat at low doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the downsides of dopamine agonists?

A

It comes with postural hypotension which can be a symptom of Parkinson’s

It is less effective at managing motor symptoms so less improvement to quality of life

More adverse reactions

Impulse control disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When are MOAb inhibitors given?

A

In young people who do not want to be on levodopa

As a levodopa-sparing method in late PD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is end of dose deterioration?

A

Disease progression and a loss of capacity to store dopamine

So there is less on time with levodopa

17
Q

What are the causes of end of dose deterioration?

A

Long-term levodopa therapy

Dopamine isn’t being stored due to less dopaminergic neurons with the progression of disease

Effects start to wear off at an earlier point

Delay in returning to on time due to GI malabsorption and competition with amino acids at the BBB

18
Q

What are the issues and risk factors with levodopa-induced dyskinesia?

A

Risk of falls and weight loss due to muscle waste

The severity of dyskinesia is associated with depression

Risk factors: low body weight, high doses and young age

19
Q

How is levodopa therapy optimised?

A

Levodopa-sparing therapy

Smaller, more frequent doses

Using MR preparation